“I’d never heard of med comms until I wanted to change career and started exploring my options” – it’s a …

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …

Boehringer Ingelheim has unveiled opnME.com, a centralised platform which makes available selected pre-clinical molecules from its portfolio for free, accessible …

A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and …

The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …

In a decision that was likened to a penalty shoot-out, Amsterdam was announced as the winner of the race to …

Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be …

Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …

A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …

Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …

Novartis’s Tasigna (nilotinib) has received European Commission approval for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in …

Samsung Bioepis has announced that Ontruzant, the company’s biosimilar version of Roche’s Herceptin, has been awarded marketing authorisation in Europe …

A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …

It’s Friday, and it’s time for another rundown of our most popular articles with our readers this week. Besides a …

Pfizer has announced that the FDA has expanded the use of its tyrosine kinase inhibitor Sutent (sunitinib malate) to include …

Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …

Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own …

Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services (HHS) agency, …

A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …

A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …